KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Amortizatization of Intangibles (2019 - 2025)

Edwards Lifesciences (EW) has 7 years of Amortizatization of Intangibles data on record, last reported at $6.6 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 6.45% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $25.9 million, down 6.83%, while the annual FY2025 figure was $25.9 million, 6.83% down from the prior year.
  • Amortizatization of Intangibles reached $6.6 million in Q4 2025 per EW's latest filing, down from $6.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $7.7 million in Q1 2024 and bottomed at $6.1 million in Q1 2025.
  • Average Amortizatization of Intangibles over 5 years is $6.9 million, with a median of $6.8 million recorded in 2022.
  • Peak YoY movement for Amortizatization of Intangibles: increased 13.64% in 2023, then decreased 20.78% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $7.1 million in 2021, then fell by 7.04% to $6.6 million in 2022, then rose by 13.64% to $7.5 million in 2023, then fell by 17.33% to $6.2 million in 2024, then rose by 6.45% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $6.6 million in Q4 2025, $6.8 million in Q3 2025, and $6.4 million in Q2 2025.